Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
José Baselga of Memorial Sloan Kettering took millions of dollars from drug and health care companies but did not report the payments in his research articles.
An email exchange and an unusual meeting suggest a connection between an institute’s pursuit of industry support and the rejection of a grant application.
A leading scientific voice among global warming skeptics received funding from the energy industry while publishing claims that climate change is not driven by human activity.